Form 4: Cytek Biosciences SVP Philippe Busque Reports Stock Transactions
SEC Form 4 Filing
Philippe Busque, SVP of Global Sales and Services at Cytek Biosciences, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On May 19, 2025, Philippe Busque, SVP of Global Sales and Services at Cytek Biosciences, reported transactions involving common stock and restricted stock units (RSUs).
- Busque acquired shares through the vesting of RSUs and simultaneously had shares withheld to cover tax obligations.
- The transactions resulted in a net change in Busque's beneficial ownership of Cytek Biosciences common stock.
- The price for the tax withholding was $2.69.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to executive compensation and stock-based awards, common in publicly traded companies. It provides transparency into the equity holdings of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 05/18/2024 | Initial vesting date for some of the RSU awards. |
| 08/18/2024 | Subsequent vesting date for some of the RSU awards. |
| 11/18/2024 | Subsequent vesting date for some of the RSU awards. |
| 03/10/2025 | Subsequent vesting date for some of the RSU awards. |
| 05/18/2025 | Subsequent vesting date for some of the RSU awards. |
| 05/19/2025 | Date of the reported transactions: RSU vesting and tax withholding. |
| 05/21/2025 | Date of the Form 4 filing. |
| 08/18/2025 | Future vesting date for some of the RSU awards. |
| 11/18/2025 | Future vesting date for some of the RSU awards. |
| 03/10/2026 | Future vesting date for some of the RSU awards. |
Keywords
Cytek Biosciences, Form 4, Philippe Busque, RSU, Stock transaction, Beneficial ownership, Vesting, Tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.